Overexpression of CXC Chemokine Receptors Is Required for the Superior Glioma-Tracking Property of Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Reference-Cited by-同舟云学术

Overexpression of CXC Chemokine Receptors Is Required for the Superior Glioma-Tracking Property of Umbilical Cord Blood-Derived Mesenchymal Stem Cells

Published:2009-04 Issue:3 Volume:18 Page:511-520
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Kim Dal-Soo¹,Kim Ji Hyun¹,Kwon Lee Jae²,Choi Soo Jin¹,Kim Jae-Sung³,Jeun Sin-Soo⁴,Oh Wonil¹,Yang Yoon Sun¹,Chang Jong Wook¹

Affiliation:

1. Biomedical Research Institute, MEDIPOST Co., Ltd., Republic of Korea.

2. Department of Science Education (Biology), College of Education, Chungbuk National University, Chungcheongbuk-Do, Republic of Korea.

3. Laboratory of Radiation Cancer Biology, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.

4. Department of Neurosurgery, The Catholic University of Korea, Seoul, Republic of Korea.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2008.0050

Reference28 articles.

1. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

2. Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

3. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines

4. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)

5. Multilineage Potential of Adult Human Mesenchymal Stem Cells

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating Proliferation, Migration and Differentiation of Mesenchymal Stem Cells Using Interleukins;Current Stem Cell Research & Therapy;2024-06-03

2. The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors;International Journal of Molecular Sciences;2024-04-15

3. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review;Experimental Hematology & Oncology;2024-04-13

4. Impaired receptivity of thin endometrium: therapeutic potential of mesenchymal stem cells;Frontiers in Endocrinology;2024-01-25

5. Tumor-tropic Trojan horses: Using mesenchymal stem cells as cellular nanotheranostics;Theranostics;2024